128 related articles for article (PubMed ID: 35895152)
21. Fibril growth and seeding capacity play key roles in α-synuclein-mediated apoptotic cell death.
Mahul-Mellier AL; Vercruysse F; Maco B; Ait-Bouziad N; De Roo M; Muller D; Lashuel HA
Cell Death Differ; 2015 Dec; 22(12):2107-22. PubMed ID: 26138444
[TBL] [Abstract][Full Text] [Related]
22. T Cells Limit Accumulation of Aggregate Pathology Following Intrastriatal Injection of α-Synuclein Fibrils.
George S; Tyson T; Rey NL; Sheridan R; Peelaerts W; Becker K; Schulz E; Meyerdirk L; Burmeister AR; von Linstow CU; Steiner JA; Galvis MLE; Ma J; Pospisilik JA; Labrie V; Brundin L; Brundin P
J Parkinsons Dis; 2021; 11(2):585-603. PubMed ID: 33579871
[TBL] [Abstract][Full Text] [Related]
23. Distinct α-Synuclein strains and implications for heterogeneity among α-Synucleinopathies.
Peng C; Gathagan RJ; Lee VM
Neurobiol Dis; 2018 Jan; 109(Pt B):209-218. PubMed ID: 28751258
[TBL] [Abstract][Full Text] [Related]
24. Decrease in
Han S; Seo MH; Lim S; Yeo S
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884422
[TBL] [Abstract][Full Text] [Related]
25. Alpha-synuclein/synapsin III pathological interplay boosts the motor response to methylphenidate.
Faustini G; Longhena F; Bruno A; Bono F; Grigoletto J; La Via L; Barbon A; Casiraghi A; Straniero V; Valoti E; Costantino G; Benfenati F; Missale C; Pizzi M; Spillantini MG; Bellucci A
Neurobiol Dis; 2020 May; 138():104789. PubMed ID: 32032728
[TBL] [Abstract][Full Text] [Related]
26. Retinoic Acid Prevents α-Synuclein Preformed Fibrils-Induced Toxicity via Inhibiting STAT1-PARP1 Signaling.
Zhou L; Ma Z; Gao X
Mol Neurobiol; 2023 Aug; 60(8):4828-4841. PubMed ID: 37171576
[TBL] [Abstract][Full Text] [Related]
27. C-terminal truncation exacerbates the aggregation and cytotoxicity of α-Synuclein: A vicious cycle in Parkinson's disease.
Ma L; Yang C; Zhang X; Li Y; Wang S; Zheng L; Huang K
Biochim Biophys Acta Mol Basis Dis; 2018 Dec; 1864(12):3714-3725. PubMed ID: 30290273
[TBL] [Abstract][Full Text] [Related]
28. Prolyl oligopeptidase inhibition by KYP-2407 increases alpha-synuclein fibril degradation in neuron-like cells.
Rostami J; Jäntti M; Cui H; Rinne MK; Kukkonen JP; Falk A; Erlandsson A; Myöhänen T
Biomed Pharmacother; 2020 Nov; 131():110788. PubMed ID: 33152946
[TBL] [Abstract][Full Text] [Related]
29. Neurotoxic conversion of beta-synuclein: a novel approach to generate a transgenic mouse model of synucleinopathies?
Fujita M; Sekigawa A; Sekiyama K; Sugama S; Hashimoto M
J Neurol; 2009 Aug; 256 Suppl 3():286-92. PubMed ID: 19711118
[TBL] [Abstract][Full Text] [Related]
30. Glucocerebrosidase deficiency promotes release of α-synuclein fibrils from cultured neurons.
Gegg ME; Verona G; Schapira AHV
Hum Mol Genet; 2020 Jun; 29(10):1716-1728. PubMed ID: 32391886
[TBL] [Abstract][Full Text] [Related]
31. Modeling α-Synucleinopathy in Organotypic Brain Slice Culture with Preformed α-Synuclein Amyloid Fibrils.
Roux A; Wang X; Becker K; Ma J
J Parkinsons Dis; 2020; 10(4):1397-1410. PubMed ID: 32716318
[TBL] [Abstract][Full Text] [Related]
32. α-mangostin derivative 4e as a PDE4 inhibitor promote proteasomal degradation of alpha-synuclein in Parkinson's disease models through PKA activation.
Chen JY; Zhu Q; Cai CZ; Luo HB; Lu JH
Phytomedicine; 2022 Jul; 101():154125. PubMed ID: 35525236
[TBL] [Abstract][Full Text] [Related]
33. Astrocyte dysfunction in Parkinson's disease: from the perspectives of transmitted α-synuclein and genetic modulation.
Wang C; Yang T; Liang M; Xie J; Song N
Transl Neurodegener; 2021 Oct; 10(1):39. PubMed ID: 34657636
[TBL] [Abstract][Full Text] [Related]
34. Cellular response of human neuroblastoma cells to α-synuclein fibrils, the main constituent of Lewy bodies.
Pieri L; Chafey P; Le Gall M; Clary G; Melki R; Redeker V
Biochim Biophys Acta; 2016 Jan; 1860(1 Pt A):8-19. PubMed ID: 26468903
[TBL] [Abstract][Full Text] [Related]
35. Slow Progressive Accumulation of Oligodendroglial Alpha-Synuclein (α-Syn) Pathology in Synthetic α-Syn Fibril-Induced Mouse Models of Synucleinopathy.
Uemura N; Uemura MT; Lo A; Bassil F; Zhang B; Luk KC; Lee VM; Takahashi R; Trojanowski JQ
J Neuropathol Exp Neurol; 2019 Oct; 78(10):877-890. PubMed ID: 31504665
[TBL] [Abstract][Full Text] [Related]
36. Specific pesticide-dependent increases in α-synuclein levels in human neuroblastoma (SH-SY5Y) and melanoma (SK-MEL-2) cell lines.
Chorfa A; Bétemps D; Morignat E; Lazizzera C; Hogeveen K; Andrieu T; Baron T
Toxicol Sci; 2013 Jun; 133(2):289-97. PubMed ID: 23535362
[TBL] [Abstract][Full Text] [Related]
37. L116 Deletion in CSPα Promotes α-Synuclein Aggregation and Neurodegeneration.
Guo T; Xiong J; Feng H; Bu L; Xiao T; Zhou L; He J; Deng M; Liu Y; Zhang Z; Zhang Z
Mol Neurobiol; 2024 Jan; 61(1):15-27. PubMed ID: 37566176
[TBL] [Abstract][Full Text] [Related]
38. Cancerous Inhibitor of Protein Phosphatase 2A (CIP2A): Could It Be a Promising Biomarker and Therapeutic Target in Parkinson's Disease?
Yin S; Han C; Xia Y; Wan F; Hu J; Kou L; Sun Y; Wu J; Li Y; Zhou Q; Xiong N; Huang J; Wang T
Mol Neurobiol; 2022 Feb; 59(2):1333-1344. PubMed ID: 34984583
[TBL] [Abstract][Full Text] [Related]
39. Alpha-synuclein from patient Lewy bodies exhibits distinct pathological activity that can be propagated in vitro.
Marotta NP; Ara J; Uemura N; Lougee MG; Meymand ES; Zhang B; Petersson EJ; Trojanowski JQ; Lee VM
Acta Neuropathol Commun; 2021 Nov; 9(1):188. PubMed ID: 34819159
[TBL] [Abstract][Full Text] [Related]
40. Generation and characterization of novel conformation-specific monoclonal antibodies for α-synuclein pathology.
Vaikath NN; Majbour NK; Paleologou KE; Ardah MT; van Dam E; van de Berg WD; Forrest SL; Parkkinen L; Gai WP; Hattori N; Takanashi M; Lee SJ; Mann DM; Imai Y; Halliday GM; Li JY; El-Agnaf OM
Neurobiol Dis; 2015 Jul; 79():81-99. PubMed ID: 25937088
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
